[Federal Register Volume 64, Number 88 (Friday, May 7, 1999)]
[Notices]
[Page 24678]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-11449]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 15, 1999, Dupont 
Pharmaceuticals, 1000 Stewart Avenue, Garden City, New York 11530, made 
application by renewal to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Oxymorphone (9652).........................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
make finished products.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than July 6, 1999.

    Dated: April 26, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 99-11449 Filed 5-6-99; 8:45 am]
BILLING CODE 4410-09-M